Lupin has informed that it enclosed a Press Release as regards, receipt of approval from the U.S. FDA for launch by the Company of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, a generic equivalent of Suprep® Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc. This may be considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.
